Equifax to offer free program to lock and unlock credit files for life

The development was announced on Wednesday via a Wall Street Journal op-ed penned by interim CEO Paulino do Rego Barros Jr. He took the reins at Equifax on Tuesday, replacing Richard Smith, who oversaw the company during a massive data breach that compromised the personal information of as many as 143 million people.
In the...

Equifax to offer free program to lock and unlock credit files for life Continue reading…

U.S. brings new charges over Tenet Healthcare fraud scheme

(Reuters) - The U.S. Justice Department has brought new charges over a scheme that it says enabled Tenet Healthcare Corp to fraudulently bill state Medicaid programs for $400 million, according to an indictment made public on Wednesday.

William Moore, the ex-chief executive of Atlanta Medical Center Inc, which had been operated by Tenet; and Edmundo...

U.S. brings new charges over Tenet Healthcare fraud scheme Continue reading…

J&J conspired to cover up talc safety issues for decades, a new lawsuit alleges

In its defense against thousands of lawsuits alleging talc can cause ovarian cancer, Johnson & Johnson has said science is on its side. But a new suit in St. Louis alleges the company has "blatantly lied" for decades about talc safety—and participated in a conspiracy to conceal the truth.

Filed in St. Louis circuit...

J&J conspired to cover up talc safety issues for decades, a new lawsuit alleges Continue reading…

Lawsuit: St. Jude waited years before recalling faulty defibrillators

A collection of third-party insurance payers has filed a class-action lawsuit seeking $9.9 million from St. Jude Medical and parent company Abbott Laboratories, claiming St. Jude knew about a battery defect in its cardiac defibrillators nearly five years before issuing a recall.

Filed Sept. 18 in Chicago by law firms DiCello Levitt & Casey and...

Lawsuit: St. Jude waited years before recalling faulty defibrillators Continue reading…

FDA warns of death, liver injury risks from Intercept’s drug

(Reuters) - The U.S. Food and Drug Administration (FDA) warned on Thursday that Intercept Pharmaceuticals Inc’s drug Ocaliva was being incorrectly dosed in some patients with a rare liver disease, increasing the risk of liver injury and death.

The U.S. drugmaker’s shares fell 10.4 percent to $87.90 in afternoon trading following the news.

FDA warns of death, liver injury risks from Intercept’s drug Continue reading…

Investors seek class action status in lawsuit over St. Jude implantable defib batteries

Abbott (NYSE:ABT) is facing an investor suit from an Alaskan union-benefits fund over allegations that St. Jude Medical, which it closed its acquisition of in January, failed to notify regulators about defective lithium batteries in its implantable defibrillators.

In the lawsuit, plaintiffs allege that St. Jude was informed of the battery defect “as early as...

Investors seek class action status in lawsuit over St. Jude implantable defib batteries Continue reading…

Lawsuit seeks damages for faulty batteries in St. Jude defibrillators

An Alaska union-benefits fund is suing Abbott Laboratories over allegations that Minnesota-based medical device company St. Jude Medical, which is owned by Abbott, failed to warn the public and regulators for years that thousands of its implantable defibrillators contained defective lithium batteries.

The federal lawsuit, filed in northern Illinois late Monday, alleges that St. Jude...

Lawsuit seeks damages for faulty batteries in St. Jude defibrillators Continue reading…

Smiths Medical confirms drug pump vulnerable to cyberhacking

Smiths Medical, the Plymouth-based maker of hospital infusion pumps, confirmed earlier this month cybersecurity vulnerabilities in its Medfusion 4000 drug pumps, which are used in pediatric cases worldwide.

The company said Monday that it has received no reports of computer hackers exploiting the ­vulnerabilities.

Read More